These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
956 related items for PubMed ID: 11494139
1. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139 [Abstract] [Full Text] [Related]
2. Integration of SV40 in human osteosarcoma DNA. Mendoza SM, Konishi T, Miller CW. Oncogene; 1998 Nov 12; 17(19):2457-62. PubMed ID: 9824156 [Abstract] [Full Text] [Related]
3. Detection of authentic SV40 DNA sequences in human brain and bone tumours. Butel JS, Jafar S, Stewart AR, Lednicky JA. Dev Biol Stand; 1998 Nov 12; 94():23-32. PubMed ID: 9776222 [Abstract] [Full Text] [Related]
4. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, Pienkowska M, Lafay-Cousin L, Gozali A, Zhukova N, Shane L, Gonzalez I, Finlay J, Malkin D. J Clin Oncol; 2010 Apr 20; 28(12):1995-2001. PubMed ID: 20308654 [Abstract] [Full Text] [Related]
5. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome. Srivastava S, Tong YA, Devadas K, Zou ZQ, Sykes VW, Chen Y, Blattner WA, Pirollo K, Chang EH. Oncogene; 1992 May 20; 7(5):987-91. PubMed ID: 1373881 [Abstract] [Full Text] [Related]
6. p53 mutations in bladder carcinoma cell lines. Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J. Oncol Res; 1994 May 20; 6(12):569-79. PubMed ID: 7787250 [Abstract] [Full Text] [Related]
7. In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants. Maclean K, Rogan EM, Whitaker NJ, Chang AC, Rowe PB, Dalla-Pozza L, Symonds G, Reddel RR. Oncogene; 1994 Mar 20; 9(3):719-25. PubMed ID: 8108114 [Abstract] [Full Text] [Related]
8. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family. Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G. Oncogene; 1994 Nov 20; 9(11):3273-80. PubMed ID: 7936651 [Abstract] [Full Text] [Related]
9. T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. Chen J, Tobin GJ, Pipas JM, Van Dyke T. Oncogene; 1992 Jun 20; 7(6):1167-75. PubMed ID: 1317542 [Abstract] [Full Text] [Related]
10. Simian virus 40 DNA sequences in human brain and bone tumours. Wang J, Garcea RL. Dev Biol Stand; 1998 Jun 20; 94():13-21. PubMed ID: 9776221 [Abstract] [Full Text] [Related]
11. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome. Rieber J, Remke M, Hartmann C, Korshunov A, Burkhardt B, Sturm D, Mechtersheimer G, Wittmann A, Greil J, Blattmann C, Witt O, Behnisch W, Halatsch ME, Orakcioglu B, von Deimling A, Lichter P, Kulozik A, Pfister S. Genes Chromosomes Cancer; 2009 Jul 20; 48(7):558-68. PubMed ID: 19378321 [Abstract] [Full Text] [Related]
12. Three germline mutations in the TP53 gene. Cornelis RS, van Vliet M, van de Vijver MJ, Vasen HF, Voute PA, Top B, Khan PM, Devilee P, Cornelisse CJ. Hum Mutat; 1997 Jul 20; 9(2):157-63. PubMed ID: 9067756 [Abstract] [Full Text] [Related]
13. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS. Virology; 1995 Oct 01; 212(2):710-7. PubMed ID: 7571441 [Abstract] [Full Text] [Related]
14. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma. Cao J, Zhang ZY, Patima, Zhang YX, Chen WT. Chin J Dent Res; 2000 Nov 01; 3(3):44-9. PubMed ID: 11314535 [Abstract] [Full Text] [Related]
15. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, Wada K, Nishisaki H, Konda Y, Nagao M. Cancer Res; 1992 Aug 15; 52(16):4335-41. PubMed ID: 1322785 [Abstract] [Full Text] [Related]
16. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T. Cell; 2004 Dec 17; 119(6):847-60. PubMed ID: 15607980 [Abstract] [Full Text] [Related]
17. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Stolzenberg MC, Brugières L, Gardes M, Dessarps-Freichey F, Chompret A, Bressac B, Lenoir G, Bonaïti-Pellié C, Lemerle J, Feunteun J. Oncogene; 1994 Oct 17; 9(10):2799-804. PubMed ID: 8084585 [Abstract] [Full Text] [Related]
18. [Germline mutations of the p53 gene]. Frebourg T. Pathol Biol (Paris); 1997 Dec 17; 45(10):845-51. PubMed ID: 9769948 [Abstract] [Full Text] [Related]
19. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D. Cancer Res; 1994 Mar 01; 54(5):1298-304. PubMed ID: 8118819 [Abstract] [Full Text] [Related]
20. Germ-line splicing mutation of the p53 gene in a cancer-prone family. Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G. Cell Growth Differ; 1992 Nov 01; 3(11):839-46. PubMed ID: 1467311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]